1 / 32

Amorolfine nail lacquer in onychomycosis

Amorolfine nail lacquer in onychomycosis. Amorolfine. Chemically stable. Data on file; Galderma International. Amorolfine: mode of action. Dual inhibition of sterol biosynthesis very potent fungistatic agent + fungicidal agent. Kerkenaar A. Ed.RA Fromtling, 1987

ryan-bell
Download Presentation

Amorolfine nail lacquer in onychomycosis

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Amorolfine nail lacquer in onychomycosis

  2. Amorolfine • Chemically stable Data on file; Galderma International

  3. Amorolfine: mode of action Dual inhibition of sterol biosynthesis very potent fungistatic agent + fungicidal agent Kerkenaar A. Ed.RA Fromtling, 1987 Polak A et al., Handbook of Experimental Pharmacology, 1990

  4. Antifungal Activity of Amorolfine In Vitro Polak A et al, Ed. RA Fromtling, 1987

  5. Antifungal Activity of Amorolfine In VitroSummary Broad spectrum activity • Dermatophytes • Yeasts • Moulds Polak A et al, Ed. RA Fromtling, 1987 Polak A et al, Handbook of Exp Pharmacol, 1990 

  6. Amorolfine: mode of action 24h-culture with 8ng/ml of Amorolfine 48h-culture with 80ng/ml of Amorolfine Control Dermatophytes Nishiyama Y. et al, Clin Exp Dermatol 1992

  7. Amorolfine: mode of action Survival curve of yeasts - concentration of 3 microgrammes killed up to 100% of the cells in 7 days Polak A. et al., Handbook of Experimental Pharmacology 1990 Hay R., 8th EADV, 1999

  8. Amorolfine: mode of action Control 24h-culture with 100μg/ml of Amorolfine 48h-culture with 100μg/ml of Amorolfine Yeasts Muller J. et al., Clin Exp Dermatol 1992

  9. Amorolfine: Resistance • 400 strains of Candida sp. And Trichophyton sp. were used for sensitivity testing. • 20 strains of Candida albicans and 3 strains of Trichophyton were used to test the resistance frequency and selection of resistant mutants. None of the 400 strains tested for sensitivity showed primary resistance to amorolfine, and no fully resistant strains were detected. Polak A., Research Report B-102’098 1988

  10. ONYCHOMYCOSISRationale for topical therapy Systemic drugs • Failure rate at least 20-25% • Systemic side effects • Drug interactions • Risk of resistance • High cost Topical • Compliance • Local care • Safe • Lower cost Epstein E., Arch Dermatol 1998

  11. Amorolfine nail lacquer:Galenic characteristics

  12. Amorolfine nail lacquer Formulation AMOROLFINE Solution Active - 5% Polymer (methacrylic acid copolymer) Plasticizer (triacetin) Solvent (ethanol) Marty J., Eur Ac Dermatol Venereol 1995

  13. Amorolfine nail lacquer Selection of vehicle Vehicle: Compatible with active ingredient, optimises penetration Molecule characteristics: Hydrophilicity, partition coefficient Nail structure: Keratin, low % lipids, water gel membrane

  14. Amorolfine nail lacquer Penetration - Vehicle Film (Polymer + Plasticizer) Solvent (ethanol) evaporation INCREASED PENETRATION Occlusion Hyperconcentration (amorolfine 25%) Marty J.P.; J. Eur. Acad. Dermatol. Venereol. 1995

  15. Why is the degree of penetration so important?

  16. OnychomycosisClinical Forms SUPERFICIAL ONYCHOMYCOSIS Courtesy Baran R., Hay R., Tosti A. & Haneke E., 1998

  17. OnychomycosisClinical Forms DISTAL SUBUNGUAL ONYCHOMYCOSIS Courtesy Baran R., Hay R., Tosti A. & Haneke E., 1998 Ref: Baran, Hay, Tosti & Haneke, 1998

  18. Amorolfine nail lacquer Penetration studies • Amorolfine penetrates efficiently into the nail plate • Amorolfine permeates through the horny tissue into the nail bed • Amorolfine accumulates to high enough concentrations for long enough periods of time • Amorolfine nail lacquer efficient penetration

  19. Pig hoof horn 1.8% of the applied dose is delivered into the nail bed in 7 days (500 µg/cm²) Provedpermeation Amorolfine nail lacquer Penetrationstudies Pittrof F et al. Clin Exp Dermatol, 1992

  20. Human nails After 24 hours, the amorolfine concentration in the nail is already above the minimal inhibitory concentration of most fungi causing onychomycosis. Proved penetration Amorolfine nail lacquer Penetrationstudies Polak A., Mycoses ,1993 Franz T.J, Dermatology, 1992

  21. Diseased nails 1,2 Antifungal activity in subungual material for up to 7 (1)-14 (2)days after application Proved penetration Supports once weekly regimen Amorolfine nail lacquer Penetrationstudies Mensing H et al., Revista Iberica de Micologia, 1988. Mensing H et al., Clin Exp Dermatol, 1992 

  22. Amorolfine nail lacquer Penetration highlights Penetration into the nail platePenetration through the horny tissue into the nail bed Anti-mycotic concentration in the nail bed for at least 7 days More rapid penetration and higher concentrations than oral terbinafine and itraconazole therapies Polak A., Mycoses ,1993

  23. Amorolfine nail lacquer PK study

  24. Pharmacokinetic study in 20 patients with onychomycosis Maximal clinical dose of amorolfine applied twice weekly for 3 months to all nails (phase I) Then, same dosage regimen only to affected nails for 9 additional months (phase II) • Plasma levels were not measurable in half of the patients and were low (between 0.1 and 0.5 ng/mL) in the other half • No difference between phase I and phase II • No apparent accumulation during either maximal use or therapeutic use Mistry GC., Research Report N-132’521 1994

  25. Pharmacokinetic study in patients with onychomycosis Amorolfine applied once or twice weekly for up to 13 months during a phase III study In the 19 tested patients, plasma levels were below the quantification limit of 0.5 ng/mL Roncari G., Research Report B-155’051 1989

  26. Amorolfine nail lacquer Clinical studies

  27. Amorolfine lacquer - Monotherapy Double-blind, randomised, multicentre trial comparing two concentrations (2 and 5%) of amorolfine nail lacquer applied once weekly over 6 months in patients suffering from onychomycosis Lauharanta J., Clin. And Exp. Dermatology, 1992

  28. Amorolfine lacquer2% vs 5%Study Design • 157 patients (44 ± 12 years) presenting fingernails and/or toenail onychomycosis with involvement of no more than 80% of nail surface, treated for 6 months • Efficacy criteria Primary: Overall response (combination of clinical and mycological response), 3 months after treatment discontinuation Secondary: Mycological response / Overall clinical response / Overall assessment Lauharanta J., Clin. And Exp. Dermatology, 1992

  29. Amorolfine lacquer2% vs 5%Efficacy results % cure N= 100 evaluable Lauharanta J., Clin. And Exp. Dermatology, 1992

  30. Amorolfine lacquer - Monotherapy Open, randomised, multicentre dose-finding trial comparing amorolfine 5% nail lacquer applied either once or twice weekly up to 6 months in patients suffering from onychomycosis Reinel R., Dermatology 1992

  31. Amorolfine lacquerOnce vs twice weekly useStudy Design • 456 patients (44 ± 13 years) presenting fingernails and/or toenail onychomycosis with involvement of no more than 80% of nail surface, treated for 6 months • Efficacy criteria Primary: Overall response (combination of clinical and mycological response), 3 months after treatment discontinuation Secondary: Mycological response / Overall clinical response / Overall assessment Reinel R., Dermatology 1992

  32. Amorolfine lacquerOnce vs twice weekly useEfficacy results % cure N= 261 evaluable Reinel R., Dermatology 1992

More Related